In 2019, cardiovascular system drugs were the leading therapeutic sector for drug products in South Korea, based on its production value amounting to over 3.7 trillion South Korean won. This is an increase in value of around 200 billion won compared to the previous year.
Leading therapeutic sectors for drug products in South Korea in 2019, by production value (in billion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Number of pharmaceutical distributors South Korea 2012-2022
- Premium Statistic Number of pharmaceutical distributors South Korea 2022, by type
- Premium Statistic Number of pharmaceutical manufacturers South Korea 2012-2022
- Premium Statistic OTC drug products production value South Korea 2012-2022
- Premium Statistic Leading countries for pharmaceutical imports South Korea 2022, by import value
- Premium Statistic Leading pharmaceutical companies South Korea 2022, by production value
- Premium Statistic Leading pharmaceutical products South Korea 2022, by production value
- Premium Statistic Leading countries for pharmaceutical exports South Korea 2022, by export value
- Basic Statistic Americans' impression of the pharma industry quality of drugs by age 2017
- Basic Statistic Americans' impression of the US pharma industry quality of drugs, by gender 2017
About the region
10
- Premium Statistic Number of employees in the South Korean pharmaceutical industry 2019, by sector
- Basic Statistic Pharmaceutical production value South Korea 2012-2022
- Basic Statistic Number of clinical trials for new drugs in South Korea 2010-2020
- Premium Statistic Number of new pharmaceutical drug approvals in South Korea 2014 by therapeutic area
- Premium Statistic Prescription drug products production value South Korea 2012-2022
- Premium Statistic New pharmaceutical drugs in R&D pipelines in South Korea 2014, by therapeutic area
- Premium Statistic Pharmaceuticals market size South Korea 2012-2022
- Premium Statistic Net income Yuhan 2015-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2023
- Premium Statistic Net profit Hanmi Pharmaceutical 2017-2022
Selected statistics
10
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic U.S. branded prescription revenue forecast 2009-2015
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
Other regions
10
- Basic Statistic U.S. health care spending growth 2010-2019, by sector
- Basic Statistic Number of NAS approved by Health Canada 2014-2021
- Premium Statistic Expenditure for self-medication products in Italy 2013-2022
- Basic Statistic Price disparities for top product Symbicort - U.S. and international 2024
- Premium Statistic Cost structure of the health insurance system by expenditure in Germany 2021
- Basic Statistic Value of generic pharmaceutical market in Turkey 2010-2022
- Basic Statistic Value of pharmaceutical sales in Latvia 2003-2022
- Basic Statistic Public expenditure on blue prescriptions in Norway 2012-2021
- Basic Statistic Express Scripts' revenue 2006-2017
- Premium Statistic Health expenditure on pharmaceuticals and medical non-durables in Greece 2005-2015
Related statistics
10
- Premium Statistic Sales revenue from medicine raw material exports Yuhan 2016-2023
- Premium Statistic Sales revenue Yuhan 2015-2023
- Premium Statistic Operating income Yuhan 2015-2022
- Premium Statistic Sales revenue from non-prescription drugs Yuhan 2016-2022
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Premium Statistic Sales revenue of JW Pharmaceutical 2014-2022
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
Further related statistics
10
- Expenditure worldwide on diabetes by market 2013-2018
- Key figures on established biotech centers worldwide 2012-2016
- Medicinal market growth worldwide including rebates 2009-2018
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Number of employees at Sinopharm 2011-2022
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Sinopharm 2010-2022
Further Content: You might find this interesting as well
Statistics
- Expenditure worldwide on diabetes by market 2013-2018
- Key figures on established biotech centers worldwide 2012-2016
- Medicinal market growth worldwide including rebates 2009-2018
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Number of employees at Sinopharm 2011-2022
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Sinopharm 2010-2022
MFDS (South Korea). (December 21, 2020). Leading therapeutic sectors for drug products in South Korea in 2019, by production value (in billion South Korean won) [Graph]. In Statista. Retrieved May 21, 2024, from https://www.statista.com/statistics/1073789/south-korea-therapeutic-sectors-for-drug-products-by-production-value/
MFDS (South Korea). "Leading therapeutic sectors for drug products in South Korea in 2019, by production value (in billion South Korean won)." Chart. December 21, 2020. Statista. Accessed May 21, 2024. https://www.statista.com/statistics/1073789/south-korea-therapeutic-sectors-for-drug-products-by-production-value/
MFDS (South Korea). (2020). Leading therapeutic sectors for drug products in South Korea in 2019, by production value (in billion South Korean won). Statista. Statista Inc.. Accessed: May 21, 2024. https://www.statista.com/statistics/1073789/south-korea-therapeutic-sectors-for-drug-products-by-production-value/
MFDS (South Korea). "Leading Therapeutic Sectors for Drug Products in South Korea in 2019, by Production Value (in Billion South Korean Won)." Statista, Statista Inc., 21 Dec 2020, https://www.statista.com/statistics/1073789/south-korea-therapeutic-sectors-for-drug-products-by-production-value/
MFDS (South Korea), Leading therapeutic sectors for drug products in South Korea in 2019, by production value (in billion South Korean won) Statista, https://www.statista.com/statistics/1073789/south-korea-therapeutic-sectors-for-drug-products-by-production-value/ (last visited May 21, 2024)
Leading therapeutic sectors for drug products in South Korea in 2019, by production value (in billion South Korean won) [Graph], MFDS (South Korea), December 21, 2020. [Online]. Available: https://www.statista.com/statistics/1073789/south-korea-therapeutic-sectors-for-drug-products-by-production-value/